These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17259380)

  • 1. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.
    Usui HK; Shikata K; Sasaki M; Okada S; Matsuda M; Shikata Y; Ogawa D; Kido Y; Nagase R; Yozai K; Ohga S; Tone A; Wada J; Takeya M; Horiuchi S; Kodama T; Makino H
    Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
    Hamada Y; Fukagawa M
    Kobe J Med Sci; 2007; 53(1-2):53-61. PubMed ID: 17582205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
    Lassila M; Seah KK; Allen TJ; Thallas V; Thomas MC; Candido R; Burns WC; Forbes JM; Calkin AC; Cooper ME; Jandeleit-Dahm KA
    J Am Soc Nephrol; 2004 Aug; 15(8):2125-38. PubMed ID: 15284298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Daniel C; Schaub K; Amann K; Lawler J; Hugo C
    Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX; Wang JJ; Lu K; Mott R; Longeras R; Ma JX
    J Am Soc Nephrol; 2006 Feb; 17(2):475-86. PubMed ID: 16394111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM; del Re E; Brown D; Lin HY
    Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of growth arrest-specific gene 6 in diabetic nephropathy.
    Arai H; Nagai K; Doi T
    Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
    Lassila M; Jandeleit-Dahm K; Seah KK; Smith CM; Calkin AC; Allen TJ; Cooper ME
    J Am Soc Nephrol; 2005 Feb; 16(2):363-73. PubMed ID: 15625075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
    Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
    Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
    J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ; Denner L; Schrijvers BF; Tilton RG; Rasch R; Flyvbjerg A
    J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction.
    Tsujita K; Kaikita K; Hayasaki T; Honda T; Kobayashi H; Sakashita N; Suzuki H; Kodama T; Ogawa H; Takeya M
    Circulation; 2007 Apr; 115(14):1904-11. PubMed ID: 17389263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological roles of advanced glycation end product receptors SR-A and CD36.
    Horiuchi S; Unno Y; Usui H; Shikata K; Takaki K; Koito W; Sakamoto Y; Nagai R; Makino K; Sasao A; Wada J; Makino H
    Ann N Y Acad Sci; 2005 Jun; 1043():671-5. PubMed ID: 16037291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxal phosphate prevents progression of diabetic nephropathy.
    Nakamura S; Li H; Adijiang A; Pischetsrieder M; Niwa T
    Nephrol Dial Transplant; 2007 Aug; 22(8):2165-74. PubMed ID: 17449494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
    Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
    Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class A scavenger receptor (CD204) attenuates hyperoxia-induced lung injury by reducing oxidative stress.
    Kobayashi H; Sakashita N; Okuma T; Terasaki Y; Tsujita K; Suzuki H; Kodama T; Nomori H; Kawasuji M; Takeya M
    J Pathol; 2007 May; 212(1):38-46. PubMed ID: 17370294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.